tanshinone has been researched along with Colitis Gravis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Jiang, S; Kong, D; Wang, W; Wang, Y; Wu, X; Zhao, Y; Zhu, G | 1 |
Duan, JA; Gu, JF; Guo, JM; Peng, KY; Qian, DW; Su, SL; Zhu, Y | 1 |
Chen, X; Guo, Y; Lu, Y; Shi, J; Wu, Q; Wu, X | 1 |
3 other study(ies) available for tanshinone and Colitis Gravis
Article | Year |
---|---|
The application of omics techniques to evaluate the effects of Tanshinone IIA on dextran sodium sulfate induced ulcerative colitis.
Topics: Abietanes; Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Dextran Sulfate; Mice; Taurine | 2022 |
Salvia miltiorrhiza stems and leaves total phenolic acids combination with tanshinone protect against DSS-induced ulcerative colitis through inhibiting TLR4/PI3K/AKT/mTOR signaling pathway in mice.
Topics: Abietanes; Animals; Colitis, Ulcerative; Dextran Sulfate; Drug Therapy, Combination; Hydroxybenzoates; Male; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Plant Extracts; Plant Leaves; Plant Stems; Proto-Oncogene Proteins c-akt; Salvia miltiorrhiza; Toll-Like Receptor 4; TOR Serine-Threonine Kinases | 2021 |
Dihydrotanshinone I, a natural product, ameliorates DSS-induced experimental ulcerative colitis in mice.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Colitis, Ulcerative; Dextran Sulfate; Dose-Response Relationship, Drug; HT29 Cells; Humans; Male; Mice; Mice, Inbred C57BL; RAW 264.7 Cells | 2018 |